IperionX (ADR) (IPX)
Processes recycled titanium while developing a domestic mineral supply source.
$21.53
Pre-market+0.18 (+0.84%)
At close$21.35(+2.99%)
In millions of USD, except per-share figures
| In millions | Q4 FY20Jun 2020 | Q2 FY21Dec 2020 | Q4 FY21Jun 2021 | Q2 FY22Dec 2021 | Q4 FY22Jun 2022 | Q2 FY23Dec 2022 | Q4 FY23Jun 2023 | Q2 FY24Dec 2023 | Q4 FY24Jun 2024 | Q2 FY25Dec 2024 | Q4 FY25Jun 2025 | Q2 FY26Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 1 | 2 |
| Gross profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −2 | −1 | −2 |
| 0 | 0 | 8 | 0 | 0 | 0 | — | 0 | 12 | 0 | 39 | 35 | |
| Research & development | 0 | 0 | 0 | 0 | 0 | 0 | — | 0 | 0 | 0 | 13 | 11 |
| 0 | 0 | 8 | 0 | 0 | 0 | — | 0 | 0 | 0 | 27 | 24 | |
| Selling & marketing | 0 | 0 | 0 | 0 | 0 | 0 | — | — | — | 0 | 0 | 0 |
| General & administrative | 0 | 0 | 4 | 0 | 0 | 0 | — | — | — | 0 | 27 | 0 |
| Other expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12 | 0 | 0 | 0 |
| Operating income | 0 | 0 | −8 | 0 | 0 | 0 | — | −10 | 0 | −20 | −19 | −37 |
| 0 | 0 | −5 | 0 | 0 | 0 | — | 0 | — | 4 | 0 | 2 | |
| Interest income | 0 | 0 | 0 | 0 | 0 | 0 | — | 0 | 0 | 9 | −7 | 1 |
| Interest expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Other non-operating income | 0 | 0 | 0 | 0 | 0 | 0 | — | 0 | 0 | 0 | 0 | 0 |
| Income before tax | 0 | 0 | −13 | 0 | 0 | 0 | — | −11 | 0 | 0 | −19 | −35 |
| Net income from continuing operations | 0 | 0 | −13 | 0 | 0 | 0 | — | −11 | 0 | 0 | −35 | −35 |
| Net income | 0 | 0 | −13 | 0 | 0 | 0 | — | 0 | 0 | 0 | −35 | −35 |
| EPS, basic | $0.00 | −$0.00 | −$0.75 | −$0.00 | −$0.00 | −$0.00 | −$0.00 | −$5.00 | −$0.05 | −$0.06 | −$0.00 | −$10.40 |
| EPS, diluted | $0.00 | −$0.00 | −$0.75 | −$0.00 | −$0.00 | −$0.00 | −$0.00 | −$5.00 | −$0.05 | −$0.06 | −$0.00 | −$10.40 |
| Weighted average shares, basic | 13 | 13 | 13 | 13 | 14 | 15 | 19 | 21 | 23 | 27 | 29 | 3 |
| Weighted average shares, diluted | 13 | 13 | 13 | 13 | 14 | 15 | 19 | 21 | 23 | 27 | 29 | 3 |
| EBITDA | 0 | 0 | −9 | 0 | 0 | 0 | — | 0 | 0 | 0 | −38 | −35 |
| Depreciation & amortization | 0 | 0 | 0 | 0 | 0 | 0 | — | — | — | — | 1 | 2 |
| EBIT | 0 | 0 | −9 | 0 | 0 | 0 | — | 0 | 0 | 0 | −39 | −37 |
